anti-CCR8 therapy (Oncurious/VIB)

N/A

Report date: 2025/01/26 18:04:02

Base Information

Drug Nameanti-CCR8 therapy (Oncurious/VIB)
Drug Alias Nameanti-chemokine receptor CCR8 antibody (Oncurious/VIB)T-regulatory cell depleting antibody (Oncurious/VIB)Treg modulator (Oncurious/VIB)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionC-C chemokine receptor type 8 modulators
TargetsC-C chemokine receptor type 8
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFlanders Institute for Biotechnology VZW
China Registration ClassN/A

Develop Information

Active CompaniesFlanders Institute for Biotechnology VZWOncurious Nv
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A